BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...

The next head of Europe's CERN physics laboratory said Thursday that he favored moving forward with plans for a giant particle collider far more powerful than the collider that discovered the famous ...

Particle Sciences, Inc (PSI), has completed the manufacturing of clinical supplies for the first in human studies of KX2-361 (KX02), Kinex Pharmaceuticals’ small molecule Src/pre-tublin inhibitor.

BETHLEHEM, Pa., April 1, 2014 /PRNewswire/ -- Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), today announced that they have entered into an exclusive ...

Contract drug developer and manufacturer Particle Sciences Inc. has been renamed Lubrizol Life Science Health, five years after it was acquired by Lubrizol Corp. Lubrizol initially retained the name ...

Toxicology specialist Calvert Labs is joining forces with the formulation experts at Particle Sciences to offer an early-stage service package designed to speed up drug development. The collaboration ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Some of the most fundamental questions about our universe are also the most difficult to answer. Questions like what gives matter its mass, what is the invisible 96 percent of the universe made of, ...